TGF-β prevents eosinophilic lung disease but impairs pathogen clearance
- 1 March 2005
- journal article
- Published by Elsevier in Microbes and Infection
- Vol. 7 (3) , 365-374
- https://doi.org/10.1016/j.micinf.2004.11.012
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The CD16+ (FcγRIII+) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue SettingThe Journal of Experimental Medicine, 2002
- Transforming growth factor-β in T-cell biologyNature Reviews Immunology, 2002
- Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathologyEuropean Journal of Immunology, 2001
- TGF-β SIGNAL TRANSDUCTIONAnnual Review of Biochemistry, 1998
- TGF-β1 Alters APC Preference, Polarizing Islet Antigen Responses toward a Th2 PhenotypeImmunity, 1998
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Analysis of the local kinetics and localization of interleukin‐1α, tumour necrosis‘qc factor‐α and transforming growth factor‐β, during the course of experimental pulmonary tuberculosisImmunology, 1997
- A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells.The Journal of Experimental Medicine, 1996
- Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.The Journal of Experimental Medicine, 1996
- Summer-Type Hypersensitivity Pneumonitis.Internal Medicine, 1995